BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 21999245)

  • 21. Clinical and molecular epidemiology of nursing home-associated Staphylococcus aureus bacteremia.
    Lesse AJ; Mylotte JM
    Am J Infect Control; 2006 Dec; 34(10):642-50. PubMed ID: 17161739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Staphylococcus aureus bloodstream infections in older adults: clinical outcomes and risk factors for in-hospital mortality.
    Big C; Malani PN
    J Am Geriatr Soc; 2010 Feb; 58(2):300-5. PubMed ID: 20070420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staphylococcus aureus bacteraemia in Iceland, 1995-2008: changing incidence and mortality.
    Asgeirsson H; Gudlaugsson O; Kristinsson KG; Heiddal S; Kristjansson M
    Clin Microbiol Infect; 2011 Apr; 17(4):513-8. PubMed ID: 20491831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staphylococcus aureus bacteraemia of unknown primary source: where do we stand?
    Saginur R; Suh KN
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S21-5. PubMed ID: 18757183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia.
    Cheong HS; Kang CI; Kwon KT; Heo ST; Wi YM; Kim ES; Lee JS; Ko KS; Chung DR; Lee NY; Song JH; Peck KR
    J Antimicrob Chemother; 2007 Dec; 60(6):1355-60. PubMed ID: 17923453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of community-onset methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: a hospital-based study.
    Chen LY; Chen LK; Chang CW; Kuo SC; Li LF; Chan YJ; Wang FD
    Arch Gerontol Geriatr; 2012; 55(1):152-6. PubMed ID: 21820190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2017.
    Coombs GW; Daley DA; Lee YT; Pang S
    Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Staphylococcus aureus bacteraemia: incidence, risk factors and predictors for death in a Brazilian teaching hospital.
    Guilarde AO; Turchi MD; Martelli CM; Primo MG
    J Hosp Infect; 2006 Jul; 63(3):330-6. PubMed ID: 16713018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children.
    Hultén KG; Kaplan SL; Gonzalez BE; Hammerman WA; Lamberth LB; Versalovic J; Mason EO
    Pediatr Infect Dis J; 2006 Apr; 25(4):349-53. PubMed ID: 16567988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of community-acquired Staphylococcus aureus bacteremia.
    Chi CY; Wong WW; Fung CP; Yu KW; Liu CY
    J Microbiol Immunol Infect; 2004 Feb; 37(1):16-23. PubMed ID: 15060682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nationwide study of comorbidity and risk of reinfection after Staphylococcus aureus bacteraemia.
    Wiese L; Mejer N; Schønheyder HC; Westh H; Jensen AG; Larsen AR; Skov R; Benfield T;
    J Infect; 2013 Sep; 67(3):199-205. PubMed ID: 23664855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meticillin-resistant Staphylococcus aureus blood-stream infection among patients attending the emergency department of an urban tertiary-referral hospital.
    O'Connell B; McMahon G; Kelleher M; Rossney AS
    Ir Med J; 2007 Apr; 100(4):433-5. PubMed ID: 17566479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Community onset of methicillin resistant Staphylococcus aureus infections in previously healthy or health care-associated children in Argentina].
    Paganini H; Della MP; Muller B; Ezcurra G; Uranga M; Aguirre C; Kamiya M; Ensinck G; Miranda MR; Ciriaci C; Hernández C; Casimir L; Rial MJ; Schenonne N; Ronchi E; Rodríguez Mdel C; Aprile F; De Ricco C; Saito V; Vrátnica C; Pons L; Ernst A; Morinigo S; Toffoli M; Bosque C; Monzani V; Mónaco A; Pinheiro JL; López Mdel P; Maninno L; Sarkis C
    Rev Chilena Infectol; 2009 Oct; 26(5):406-12. PubMed ID: 19915748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive factors of meticillin resistance among patients with Staphylococcus aureus bloodstream infections at hospital admission.
    Manzur A; Vidal M; Pujol M; Cisnal M; Hornero A; Masuet C; Peña C; Gudiol F; Ariza J
    J Hosp Infect; 2007 Jun; 66(2):135-41. PubMed ID: 17513007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone and joint infection as a predictor of community-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a comparative cohort study.
    Lee JY; Chong YP; Kim T; Hong HL; Park SJ; Lee ES; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS
    J Antimicrob Chemother; 2014 Jul; 69(7):1966-71. PubMed ID: 24695351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and molecular epidemiology of community-acquired, healthcare-associated and nosocomial methicillin-resistant Staphylococus aureus in Spain.
    Rodríguez-Baño J; Angeles Domínguez M; Blas Millán A; Borraz C; Pau González M; Almirante B; Cercenado E; Padilla B; Pujol M; ;
    Clin Microbiol Infect; 2009 Dec; 15(12):1111-8. PubMed ID: 19456840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of USA300 methicillin-resistant Staphylococcus aureus on clinical outcomes of patients with pneumonia or central line-associated bloodstream infections.
    Lessa FC; Mu Y; Ray SM; Dumyati G; Bulens S; Gorwitz RJ; Fosheim G; DeVries AS; Schaffner W; Nadle J; Gershman K; Fridkin SK; ;
    Clin Infect Dis; 2012 Jul; 55(2):232-41. PubMed ID: 22523264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.
    Kim SH; Park WB; Lee KD; Kang CI; Kim HB; Oh MD; Kim EC; Choe KW
    Clin Infect Dis; 2003 Sep; 37(6):794-9. PubMed ID: 12955640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.
    Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Molina J; Lopez-Medrano F; Ruiz E; Martinez JA; Bereciartua E; Rodriguez-Lopez F; Fernandez-Mazarrasa C; Goenaga MA; Benito N; Rodriguez-Baño J; Espejo E; Pujol M;
    Clin Microbiol Infect; 2013 Nov; 19(11):1049-57. PubMed ID: 23331461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Staphylococcus aureus bacteremia.
    Jensen AG
    Dan Med Bull; 2003 Nov; 50(4):423-38. PubMed ID: 14694855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.